Bone marrow B lymphocytes in multiple myeloma and MGUS: Focus on distribution of naïve cells and memory subsets

Fanny Pojero1, Alessandra Casuccio2, Caterina Giambanco3

  • 1Dipartimento di Biopatologia e Biotecnologie Mediche, Universita' degli Studi di Palermo, Corso Tukory 211, 90134 Palermo, Italy; U.O.S.D. Laboratorio Specialistico Oncologia, Ematologia e Colture Cellulari per Uso Clinico, ARNAS Civico, Piazza Nicola Leotta 4, 90127 Palermo, Italy.

Leukemia Research
|August 24, 2016
PubMed

Insights

Multiple myeloma impacts B cell populations in bone marrow. Specific B cell subsets may serve as predictive markers for treatment response in patients with multiple myeloma (MM).

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • Multiple myeloma (MM) is characterized by abnormal plasma cell proliferation in the bone marrow (BM).
  • MM is associated with immune system defects, particularly affecting B cell compartments, influencing disease onset and progression.

Purpose of the Study:

  • To investigate the distribution of distinct B lymphocyte subsets in the BM of healthy controls and multiple myeloma patients.
  • To explore the potential of specific B cell populations as predictive markers in MM.

Main Methods:

  • Flow cytometry was employed to analyze B cell subsets: naïve/transitional (IgD(+)CD27(-)), memory unswitched (IgD(+)CD27(+)), memory switched (IgD(-)CD27(+)), and double negative (DN) (IgD(-)CD27(-)).
  • B cell distribution was compared between healthy controls, responding MM patients, and relapsing MM patients.

Main Results:

  • Healthy controls showed a higher percentage of IgD(+)CD27(+) B cells compared to responding patients.
  • Treated patients with incomplete response had an expanded DN B cell compartment compared to complete responders.
  • Stringent complete responders had a larger IgD(+)CD27(-) B cell subpopulation than other responding patients.
  • No clonal restriction was observed in any studied B cell subset.

Conclusions:

  • B cell subset alterations in the MM bone marrow microenvironment warrant further investigation, potentially linking to immunosenescence and infection risk.
  • Naïve/transitional and DN B cells may serve as predictive biomarkers in treated multiple myeloma patients.
Abstract

Related Concept Videos

Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.9K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.8K
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.3K
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
16.4K